Insmed announces proposed public offering of convertible senior notes
Insmed announced it has commenced an underwritten public offering of $300 million aggregate amount of convertible senior notes due 2025. Insmed intends to grant underwriters a 30-day option to purchase up to an additional 15 percent of the aggregate principal amount of convertible senior notes. January 22, 2018